Clearside Biomedical Inc at Needham Healthcare Conference Transcript
Good morning, everybody. This is Serge Belanger from Needham & Company. I am one of the healthcare analysts. Welcome to the 19th Annual Needham Healthcare Conference. For next session we have Clearside Biomedical and the CEO, George Lasezkay, will be providing an overview of the Company. George?
Thank you, Serge. Good morning and welcome. Thank you to Needham for including us in this conference. I am George Lasezkay, President and CEO of Clearside Biomedical. I am joined today by Dr. Tom Ciulla, our Chief Medical Officer and Chief Development Officer, as well as Charlie Deignan, our Chief Financial Officer. Tom and I will be sharing today's presentation.
We may be making forward-looking statements throughout this presentation, so please read the slide quickly but carefully. All of our SEC filings are available on our website at clearsidebio.com.
Clearside is a company that is dedicated to developing treatments that restore
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |